Recently, a delegation from Bloomage Biotechnology Corporation Limited(hereinafter referred to as "Bloomage Biotech"), a leading global biotechnology company, visited Hunan Sunshine Biotechnology Co., Ltd. (hereinafter referred to as "Sunshine Bio-Tech") for a factory inspection and exchange. The inspection focused on technical verification, production capacity assessment, and compliance review, aiming to deepen cooperation between the two companies in the fields of biomedical aesthetics and functional raw materials, laying a solid foundation for future collaborative innovation and resource complementarity.
As a benchmark enterprise in the field of biological active substances in China, Bloomage Biotech holds a globally leading market position and technological expertise in biological raw materials such as hyaluronic acid and medical aesthetic terminal products. Their proactive visit to Sunshine Bio-Tech stems from their high recognition of our company's technological breakthroughs and industrial strength in the field of biomanufacturing. As a national high-tech enterprise, we adhere to our original aspiration of "enabling people to have healthy skin and a happy life," uphold the concept that "Sunshine Bio-Tech's hydrolyzed sponge = safe hydrolyzed sponge," and consistently drive high-quality development through scientific research and innovation, winning user reputation through quality and safety.We have established a complete industrial chain from the research and development of bioactive ingredients and the purification of functional raw materials to the production of terminal products. Our core products, including hydrolyzed sponge raw materials and their finished products, have obtained multiple international authoritative certifications such as EU CPNP, US VCRP, and US-FDA, and are exported to more than 80 countries and regions worldwide, becoming a core supplier to international giants such as Estée Lauder and Shiseido.
During the inspection, the Bloomage Biotech delegation conducted a comprehensive verification of our production and operation system, visiting our core R&D base, production workshop, quality testing center, and biological extraction laboratory. At the R&D center, the delegation learned in detail about our independently developed patented biological extraction technology and observed the purification and extraction of sponge spicule and the application of finished sponge microneedle products. In the production workshop, the delegation strictly inspected our entire production process, production environment, and batch traceability system. At the quality testing center, technical personnel from both sides engaged in in-depth discussions on the testing procedures and data reports for key indicators such as raw material quality traceability, microbial limits, and product stability.
During the exchange and discussion session, the relevant person in charge) of Sunshine Bio-Tech introduced in detail the company's strategic layout, technological reserves,and production capacity planning in the professional field of Sponge spicule, emphasizing the advantages of the industry-university-research cooperation platform jointly established with multiple universities and research institutions, as well as the breakthroughs in core technologies such as biological extraction. The two parties engaged in a lively discussion on topics such as the research and development of functional biological raw materials and the innovation of medical aesthetic end products, reaching several consensuses.
This factory inspection by Bloomage Biotech serves as an authoritative verification and endorsement of Qing Tian Biotech's technological capabilities, production compliance, and market potential. In the future, the two companies will leverage this inspection as an opportunity to fully utilize their respective core strengths in technology, production capacity, and distribution channels. They will deepen collaboration in areas such as innovative biological medical aesthetic raw materials and end-product development, jointly promoting the advancement of China's biomanufacturing industry towards a high-end and international level, and providing global consumers with safer and more effective biological medical aesthetic product experiences.
